Would you like to see your presentation here, made available to a global audience of researchers?
Add your own presentation or have us affordably record your next conference.
Background Feminine hygiene wipes are widely marketed for intimate care, yet few are evaluated for safety on vulvar skin. The American Academy of Dermatology (AAD) and the American College of Obstetricians and Gynecologists (ACOG) advise avoiding ingredients such as fragrance, parabens, phthalates, methylisothiazolinone (MI), botanical sensitizers, and certain surfactants, which are known to cause irritation, allergic contact dermatitis, or endocrine disruption. This study evaluates the dermatologic safety of commonly available feminine wipes in the U.S. using ingredient-level analysis based on AAD and ACOG guidance.
Methods We identified 79 feminine wipes sold at major U.S. retailers. Product labels were reviewed for full ingredient transparency. Each product was assessed for presence of medically flagged ingredients based on AAD/ACOG recommendations. These included fragrance, MI/MCI, parabens, PEGs, propylene glycol, formaldehyde releasers, botanical allergens (e.g., lavender, menthol), dyes, and surfactants like sodium laureth sulfate. Each flagged ingredient contributed one point to a cumulative violation score. Products were stratified by safety tier: Excellent (0), Acceptable (1-2), Questionable (3-4), or Poor (≥5).
Results Only 11 of 79 products (14%) received an “Excellent” safety score. Fragrance was present in 76% of products, despite being a leading cause of vulvar allergic reactions. Other frequently flagged ingredients included propylene glycol (39%), PEG compounds (33%), and botanical sensitizers such as linalool and eugenol. Notably, many products labeled as “sensitive,” “natural,” or “pH-balanced” still contained multiple allergens or irritants. Nearly half (48%) of all wipes fell into the “Questionable” or “Poor” categories.
Conclusion Most feminine wipes on the U.S. market contain ingredients that AAD and ACOG recommend avoiding on vulvar skin. Fragrance, preservatives, and plant-derived allergens remain common, even in wipes marketed for sensitive use. These findings highlight a disconnect between marketing claims and medical safety guidelines. Dermatologists and gynecologists should counsel patients accordingly and advocate for safer formulations and clearer labeling standards.
